Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (221-230 of 342) with videos related to

Pageof 35
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugsEmilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosisLuisa Pastò, Emilio Portaccio, Benedetta Goretti, et al.
Frontiers in Neurology|November 26, 2020
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)Marianna Delussi, Eleonora Gentile, Gianluca Coppola, et al.
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2018
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosisMyintzu Min, Tim Spelman, Alessandra Lugaresi, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Brain Sciences|April 30, 2021
Migraine during COVID-19: Data from Second Wave Pandemic in an Italian CohortEleonora Gentile, Marianna Delussi, Chiara Abagnale, et al.
BMC Neurology|June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric studyChiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risksEmilio Portaccio, Lucia Moiola, Vittorio Martinelli, et al.
Pageof 35

Showing results (221-230 of 342) with videos related to

Sort By:
Pageof 35
Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugsEmilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosisLuisa Pastò, Emilio Portaccio, Benedetta Goretti, et al.
Frontiers in Neurology|November 26, 2020
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)Marianna Delussi, Eleonora Gentile, Gianluca Coppola, et al.
Journal of Neurology|April 1, 2024
Big Multiple Sclerosis Data network: an international registry research networkAnna Glaser, Helmut Butzkueven, Anneke van der Walt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2018
Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosisMyintzu Min, Tim Spelman, Alessandra Lugaresi, et al.
JAMA Neurology|July 28, 2020
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple SclerosisNathaniel Lizak, Charles B Malpas, Sifat Sharmin, et al.
Brain Sciences|April 30, 2021
Migraine during COVID-19: Data from Second Wave Pandemic in an Italian CohortEleonora Gentile, Marianna Delussi, Chiara Abagnale, et al.
BMC Neurology|June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric studyChiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risksEmilio Portaccio, Lucia Moiola, Vittorio Martinelli, et al.
Pageof 35